Femasys (FEMY) EPS (Basic) (QoQ) (2020 - 2025)
Powered by 
Analysis
Femasys (FEMY) EPS (Basic) (QoQ) (2020 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.72 Bn | 175.11 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.62 Bn | 122.40 Bn | 1.96 Bn |
| 3 | Medtronic | 116.88 Bn | 108.07 Bn | 6.34 Bn |
| 4 | Stryker | 103.99 Bn | 100.52 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.65 Bn | 63.11 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.73 Bn | 45.48 Bn | 1.35 Bn |
| 7 | Alcon | 33.00 Bn | 31.54 Bn | 1.68 Bn |
| 8 | Dexcom | 32.03 Bn | 30.08 Bn | 830.00 Mn |
| 9 | Steris | 20.70 Bn | 20.21 Bn | 684.20 Mn |
| 10 | Femasys | 9.30 Mn | 7.86 Mn | 189,391.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | 32.28% |
| Mar 31, 2025 | -1.90% |
| Dec 31, 2024 | 5.42% |
| Sep 30, 2024 | -15.37% |
| Jun 30, 2024 | -27.57% |
| Mar 31, 2024 | 42.34% |
| Dec 31, 2023 | -8.26% |
| Sep 30, 2023 | -19.96% |
| Jun 30, 2023 | 11.05% |
| Mar 31, 2023 | -1.31% |
| Dec 31, 2022 | 2.98% |
| Sep 30, 2022 | -13.23% |
| Jun 30, 2022 | 8.70% |
| Mar 31, 2022 | 30.68% |
| Dec 31, 2021 | -83.98% |
| Sep 30, 2021 | 63.28% |
| Jun 30, 2021 | 71.64% |
| Mar 31, 2021 | -6.37% |
| Dec 31, 2020 | -5.35% |
| Sep 30, 2020 | -5.54% |